Search research articles
Contact Us
Filters
Showing results (31-40 of 77) with videos related to
Page
of 8
Sort By:
Nature Reviews. Disease Primers
|
June 13, 2024
Acute lymphoblastic leukaemia
Luca Pagliaro, Sai-Juan Chen, Daniel Herranz, et al.
Science Translational Medicine
|
May 18, 2012
High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia
David Wu, Anna Sherwood, Jonathan R Fromm, et al.
Journal of Biomolecular Screening
|
March 4, 2008
High-throughput screening for daunorubicin-mediated drug resistance identifies mometasone furoate as a novel ABCB1-reversal agent
Stuart S Winter, Debbie M Lovato, Hadya M Khawaja, et al.
Blood
|
December 17, 2009
Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia
Takaomi Sanda, Xiaoyu Li, Alejandro Gutierrez, et al.
Leukemia & Lymphoma
|
January 15, 2013
Inactivation of the Cdkn2a locus cooperates with HMGA1 to drive T-cell leukemogenesis
Francescopaolo Di Cello, Surajit Dhara, Alexandra C Hristov, et al.
Blood
|
April 20, 2006
Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia
Teresa Palomero, Duncan T Odom, Jennifer O'Neil, et al.
Cancer Science
|
April 12, 2019
Epigenetic silencing of SOCS5 potentiates JAK-STAT signaling and progression of T-cell acute lymphoblastic leukemia
Nitesh D Sharma, Christian K Nickl, Huining Kang, et al.
Cancer Research
|
October 8, 2009
Enhanced leukemia cell detection using a novel magnetic needle and nanoparticles
Jason E Jaetao, Kimberly S Butler, Natalie L Adolphi, et al.
Journal of Clinical and Translational Science
|
August 22, 2022
The impact of COVID-19 on disease epidemiology, family dynamics, and social justice in Minnesota: All that you cannot see
Mark R Schleiss, Bruce Blazar, Emily P Chapman, et al.
Leukemia & Lymphoma
|
November 9, 2017
Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children's oncology group (COG) clinical trials
Michael J Burke, Meenakshi Devidas, Kelly Maloney, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 77) with videos related to
Sort By:
Page
of 8
Nature Reviews. Disease Primers
|
June 13, 2024
Acute lymphoblastic leukaemia
Luca Pagliaro, Sai-Juan Chen, Daniel Herranz, et al.
Science Translational Medicine
|
May 18, 2012
High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia
David Wu, Anna Sherwood, Jonathan R Fromm, et al.
Journal of Biomolecular Screening
|
March 4, 2008
High-throughput screening for daunorubicin-mediated drug resistance identifies mometasone furoate as a novel ABCB1-reversal agent
Stuart S Winter, Debbie M Lovato, Hadya M Khawaja, et al.
Blood
|
December 17, 2009
Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia
Takaomi Sanda, Xiaoyu Li, Alejandro Gutierrez, et al.
Leukemia & Lymphoma
|
January 15, 2013
Inactivation of the Cdkn2a locus cooperates with HMGA1 to drive T-cell leukemogenesis
Francescopaolo Di Cello, Surajit Dhara, Alexandra C Hristov, et al.
Blood
|
April 20, 2006
Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia
Teresa Palomero, Duncan T Odom, Jennifer O'Neil, et al.
Cancer Science
|
April 12, 2019
Epigenetic silencing of SOCS5 potentiates JAK-STAT signaling and progression of T-cell acute lymphoblastic leukemia
Nitesh D Sharma, Christian K Nickl, Huining Kang, et al.
Cancer Research
|
October 8, 2009
Enhanced leukemia cell detection using a novel magnetic needle and nanoparticles
Jason E Jaetao, Kimberly S Butler, Natalie L Adolphi, et al.
Journal of Clinical and Translational Science
|
August 22, 2022
The impact of COVID-19 on disease epidemiology, family dynamics, and social justice in Minnesota: All that you cannot see
Mark R Schleiss, Bruce Blazar, Emily P Chapman, et al.
Leukemia & Lymphoma
|
November 9, 2017
Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children's oncology group (COG) clinical trials
Michael J Burke, Meenakshi Devidas, Kelly Maloney, et al.
Page
of 8